跳至主要内容
临床试验/CTRI/2020/06/025840
CTRI/2020/06/025840尚未招募3 期

A randomised open label comparative clinical study to evaluate the efficacy of parnayavani swarasa and haridra churna orally in the management of nava pratishyaya w.s.r. to Coryza

Dr Meera Panigrahi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects presenting with the symptoms of Nava Pratishyaya with an onset of not more than 3 days.
  • 2. Subjects aged between 18 to 50 years.

排除标准

  • 1. Coryza associated with malignant lesions, Leprosy, TB and other Specific Acute Infective Lesions.
  • 2. Disease due to Dental infection, Trauma, Nasal polyp, Oro-antral fistula, Fistula of Frontonasal duct, Deviated nasal septum

研究者

发起方
Dr Meera Panigrahi

相似试验